255 related articles for article (PubMed ID: 24913359)
1. Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients.
Hirano R; Sakamoto Y; Tachibana N; Ohnishi M
Int J Clin Pharm; 2014 Aug; 36(4):795-9. PubMed ID: 24913359
[TBL] [Abstract][Full Text] [Related]
2. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy.
Takahashi Y; Takesue Y; Nakajima K; Ichiki K; Tsuchida T; Tatsumi S; Ishihara M; Ikeuchi H; Uchino M
J Infect Chemother; 2011 Jun; 17(3):382-7. PubMed ID: 21127934
[TBL] [Abstract][Full Text] [Related]
4. Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight.
Niwa T; Watanabe T; Suzuki A; Ohmori T; Tsuchiya M; Suzuki T; Ohta H; Murakami N; Itoh Y
Diagn Microbiol Infect Dis; 2014 May; 79(1):93-7. PubMed ID: 24565849
[TBL] [Abstract][Full Text] [Related]
5. Linezolid-associated thrombocytopenia.
Lam S
Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
[TBL] [Abstract][Full Text] [Related]
6. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia associated with linezolid therapy.
Attassi K; Hershberger E; Alam R; Zervos MJ
Clin Infect Dis; 2002 Mar; 34(5):695-8. PubMed ID: 11803505
[TBL] [Abstract][Full Text] [Related]
8. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
10. Impact of vancomycin or linezolid therapy on development of renal dysfunction and thrombocytopenia in Japanese patients.
Fujii S; Takahashi S; Makino S; Kunimoto Y; Nakata H; Noda N; Sakurai K; Miyamoto A
Chemotherapy; 2013; 59(5):319-24. PubMed ID: 24480883
[TBL] [Abstract][Full Text] [Related]
11. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid.
Soriano A; Ortega M; García S; Peñarroja G; Bové A; Marcos M; Martínez JC; Martínez JA; Mensa J
Antimicrob Agents Chemother; 2007 Jul; 51(7):2559-63. PubMed ID: 17470658
[TBL] [Abstract][Full Text] [Related]
13. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
[TBL] [Abstract][Full Text] [Related]
14. Linezolid-Induced anemia and thrombocytopenia.
Waldrep TW; Skiest DJ
Pharmacotherapy; 2002 Jan; 22(1):109-12. PubMed ID: 11794421
[TBL] [Abstract][Full Text] [Related]
15. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
Sasaki T; Takane H; Ogawa K; Isagawa S; Hirota T; Higuchi S; Horii T; Otsubo K; Ieiri I
Antimicrob Agents Chemother; 2011 May; 55(5):1867-73. PubMed ID: 21357301
[TBL] [Abstract][Full Text] [Related]
17. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid.
Kuter DJ; Tillotson GS
Pharmacotherapy; 2001 Aug; 21(8):1010-3. PubMed ID: 11718489
[No Abstract] [Full Text] [Related]
18. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y
J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446
[TBL] [Abstract][Full Text] [Related]
19. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for linezolid-associated thrombocytopenia in adult patients.
Natsumoto B; Yokota K; Omata F; Furukawa K
Infection; 2014 Dec; 42(6):1007-12. PubMed ID: 25119433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
